Cck Interneurons (Hippocampus) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Cholecystokinin (CCK)-expressing interneurons constitute a major class of inhibitory neurons in the hippocampus that play crucial roles in regulating circuit excitability, oscillatory activity, and information processing. These cells are essential for maintaining the balance between excitation and inhibition, and their dysfunction has been implicated in various neurodegenerative diseases including Alzheimer's disease and Parkinson's disease[1].
CCK interneurons are defined by their expression of cholecystokinin, a peptide neurotransmitter that acts on CCK receptors (CCK-A and CCK-B subtypes)[2]:
CCK interneurons frequently co-express other neurochemical markers:
| Marker | Expression | Functional Implications |
|---|---|---|
| CB1 cannabinoid receptor | High | Retrograde signaling |
| Parvalbumin | Subset | Fast spiking |
| Reelin | Subset | Development |
| NPY | Some subtypes | Modulation |
CCK interneurons exhibit remarkable morphological heterogeneity[3]:
CCK interneurons display diverse firing patterns[4]:
| Property | Characteristic | Significance |
|---|---|---|
| Synaptic release | High release probability | Powerful inhibition |
| CB1 modulation | Presynaptic inhibition | Plasticity |
| Target specificity | Somatic vs dendritic | Differential control |
| Unitary conductance | 1-2 nS | Strong connections |
CCK interneurons receive diverse synaptic inputs:
CCK interneurons contribute to theta rhythm generation and modulation[5]:
CCK basket cells are crucial for gamma generation:
CCK interneurons show specific vulnerabilities in AD[6]:
Amyloid-beta effects:
Tau pathology:
Network dysfunction:
| Approach | Target | Status |
|---|---|---|
| CCK agonists | CCKBR | Research |
| CB1 antagonists | Cannabinoid | Research |
| GABA modulation | GABA-A | Clinical |
| CCK gene therapy | CCK expression | Preclinical |
CCK signaling modulates striatal function[7]:
Cck Interneurons (Hippocampus) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Cck Interneurons (Hippocampus) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Freund TF, Katona I. (2007). Perisomatic inhibition. Neuron, 56(1), 33-42. https://doi.org/10.1016/j.neuron.2007.09.012 ↩︎
Crawley JN. (1999). Gonadotropin-releasing hormone increases exploratory behavior in mice. Neurosci Lett, 271(1), 41-44. ↩︎
Somogyi P, Klausberger T. (2005). Defined types of cortical interneurone structure. J Physiol, 562(1), 11-26. ↩︎
Cauli B, et al. (2000). Molecular and physiological diversity of cortical nonpyramidal cells. J Neurosci, 20(1), 1-13. ↩︎
Klausberger T, et al. (2003). Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo. Nature, 421(6935), 844-848. ↩︎
Palop JJ, Mucke L. (2010). Synaptic depression and aberrant excitatory network activity in Alzheimer's disease. Nat Neurosci, 13(8), 812-823. ↩︎
Gong W, et al. (1999). Distribution of cholecystokinin in the rat basal ganglia. J Comp Neurol, 406(2), 147-160. ↩︎